Medicine RSS Search Engine

Blog Tag: Drugs Blog Tag: Drugs RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with MyMedWormSubscribe to this data using MyMedWorm.subscribe with GoogleReaderSubscribe to this data using GoogleReader.subscribe with BloglinesSubscribe to this data using Bloglines.subscribe with MyYahooSubscribe to this data using MyYahoo.

This page shows you your search results in order of date.

4779 records returned

About adhd drugs What Parents need to Consider before medicating their childemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Unfortunately adhd drugs do not have a good reputation and have garnered a significant amount of negative publicity over the years, but it is important to remember that they do form part of the treatment that is necessary to help control the symptoms of Attention Deficit Hyperactivity Disorder.  When the treatment is effective the child who has been diagnosed with ADHD is able to lead a much better life, is able to function better academically, socially, and in all other areas of their life.  Treating ADHD in children, teenagers, and adults is actually multifaceted and will be comprised of ADHD medications, behavioral mo...
Source: Life With ADHD - September 12, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD drugs About Consider Need parents What Source Type: blogs

Rivaroxaban Redux: Drug Faces Challenges in Approval Process and Beyondemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Johnson & Johnson overcame a surprisingly negative Food and Drug Administration staff review of its blood thinner rivaroxaban yesterday to win an advisory committee endorsement of the drug after an intense day-long hearing. “You work on something for seven years . . . and it all boils down to one day,” says Duke University’s Rob Califf, who led the key Rocket AF trial that was the basis of J&J’s application and made J&J’s case to the panel yesterday. Despite the victory, the day’s discussion — and the questions raised in the staff review — underscore challenges still ahead for the drug, kno...
Source: WSJ.com: Health Blog - September 9, 2011 Category: Health Medicine and Bioethics Commentators Authors: Ron Winslow Tags: drugs FDA Heart Disease Source Type: blogs

Orphan Drugs Now "Where the Money Is," Says Willie Sutton's Ghostemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Source: Pharma Marketing Blog - September 9, 2011 Category: Pharma Commentators Tags: orphan drugs Blockbuster Source Type: blogs

A.M. Vitals: FDA Panel Says More Surgical-Mesh Studies Neededemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
More Mesh Studies: An FDA advisory panel yesterday backed plans by the agency to require pre-approval studies for new surgical-mesh products inserted transvaginally to treat pelvic-organ prolapse as well as to conduct research on products already on the market, the WSJ reports. The products, whose manufacturers include Johnson & Johnson and Boston Scientific, currently can be approved without any new research, but the safety of transvaginal mesh for organ prolapse has come into question amidst more than 1,500 reports of adverse events between 2008 and 2010. Data Breach: The names, diagnosis codes, admissions dates and othe...
Source: WSJ.com: Health Blog - September 9, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs FDA IT Medical devices Research Source Type: blogs

What Are The Best ADHD Treatment Optionsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
It is a tragedy that so many ADHD children are given amphetamine type drugs to cure their ADHD as the first option. Every other option comes much later and often when the damage is done. What are the best ADHD treatment options and why are ADHD meds NOT one of them? These ADHD drugs carry the FDA black box warning and that is the maximum level of alert for them. That means implications for heart disease, depression, suicidal thoughts and potential for drug abuse. Not convinced? You may well wonder why children are given these drugs which are fancy names for ’speed’, ‘uppers’ which are still classed ...
Source: Life With ADHD - September 9, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD drugs Best Options treatment What Source Type: blogs

Treating ADHD Without Drugs Cognitive Solutions Learning Center in Chicago Offers NonMedicinal Alternativesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Ari Goldstein, PhD, founder and director of the Cognitive Solutions Learning Center in Chicago, noticed an enormous spike over the past ten years in referrals he received for diagnosis of attention disorders. Sometimes symptoms would manifest as disruptive behavior at home or at school; sometimes academics were overwhelming due to inability to focus. What troubled Dr. Goldstein, who has a PhD from the University of Illinois in Educational Psychology and a Masters in Learning Disabilities, was that when the child received a diagnosis of ADHD (Attention Deficit Hyperactivity Disorder), of which ADD (Attention Deficit Disorde...
Source: Life With ADHD - September 9, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD Research Center Cognitive drugs learning solutions Treating Without Source Type: blogs

Dendreon Cuts Staff By 25%; High-Level Exec Departsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Other shoes are now dropping at Dendreon, which disclosed last month it was facing a significantly slower launch of its prostate-cancer treatment Provenge than it had long signaled to Wall Street. The company announced after the market closed today that it is laying off 500 employees, or about one-quarter of its work force, to get expenses better aligned with expected revenues. Among those departing is chief operating officer Hans Bishop, the highest-ranking employee to leave in the aftermath of the August debacle, which cut the company’s market cap by two-thirds. On a conference call with analysts, CEO Mitch Gold decline...
Source: WSJ.com: Health Blog - September 8, 2011 Category: Health Medicine and Bioethics Commentators Authors: Ron Winslow Tags: Cancer drugs Source Type: blogs

After a Tough Week, Xarelto Gets Thumbs-Up From FDA Panelemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
An FDA advisory panel just voted 9-2 (with one abstention) in favor of approving Xarelto to prevent stroke in atrial-fibrillation patients. Johnson & Johnson and Bayer must be breathing a sigh of relief right about now. Earlier this week prospects for the drug’s approval seemed to dim when FDA staff, in a briefing document, recommended the drug be rejected. FDA reviewers had questions about a key trial called Rocket AF that compared the drug to warfarin. Specifically, they noted that the patients in the warfarin arm of the trial were in the targeted treatment range only about 55% of the time, possibly leading to an ex...
Source: WSJ.com: Health Blog - September 8, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs FDA Heart Disease Source Type: blogs

How To Treat Adhd Picking The Best Option For Your Childemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
How to treat ADHD? There are many options. In this article, you’ll learn about the three most popular treatments for this disorder with their pros and cons, so you can make the best choice for your child. The first way to treat ADHD is with prescription drugs. This option is the preferred method of doctors those who believe in traditional medicine. Although these drugs whether stimulating drugs (like Ritalin) or not, do work well for some kids, their side effects make other kids much worse. Although you may think that this is rare, online message boards of full of complaints by parents who are concerned that prescri...
Source: Life With ADHD - September 2, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD drugs Best Option Picking Treat Source Type: blogs

Managing The Drug Shortage: Many Hospitals Are Buying “Gray Market” Drugsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Severe shortages for life-saving medications have driven a “gray market” in the wholesale drug supply industry, a watchdog group reports. And the mark-up on gray market drugs is a budget-buster, reports the Institute for Safe Medication Practices, a Philadelphia-based nonprofit organization devoted entirely to medication error prevention and safe medication use. Purchasing agents and pharmacists at 549 hospitals responded to a survey on gray market activities associated with drug shortages. The report includes chilling anecdotes from the respondents about pressure from physicians and administrators to ensure dr...
Source: Better Health - September 2, 2011 Category: Health Medicine and Bioethics Commentators Authors: RyanDuBosar Tags: Research Authenticity Costs Counterfeit drugs Drug Manufacturer Drug Shortage Ethics FDA Food and Drug Administration Gray Market Illegal Institute For Safe Medication Practices Medications Pharmaceutical Companies Pharmacy P Source Type: blogs

A.M. Vitals: Increased Cancer Risk Among Ground Zero Firefightersemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Cancer Among 9/11 Responders: Research published in the Lancet finds that firefighters who worked at Ground Zero after the 9/11 attacks were 19% more likely to later develop cancer than firefighters who didn’t work at the site, the WSJ reports. Still, experts and study authors said the study isn’t definitive and that it will take many years for data on cancer incidence to accumulate. In addition, the number of cases wasn’t large enough to draw conclusions about the rates of specific cancers, the paper says. Pulling “Firepot” Fuel: Reports of burns have led to the recall of gel fuel used in outdoor ...
Source: WSJ.com: Health Blog - September 2, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: Cancer Consumer health drugs FDA Source Type: blogs

Pfizer’s Lipitor Webpage Is Slammed By FDAemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Once again, a web page is deemed problematic by the FDA. In a letter sent by the agency earlier this week, Pfizer was chastised because its Lipitor web page made misleading representations and suggestions about several other drugs. The issue came to light, by the way, thanks to the FDA ‘Bad Ad’ program, which encourages people to file complaints about troublesome promotions (see this). What exactly did the FDA find objectionable. In its letter, the Division of Drug Marketing, Advertising, and Communications noted that the Lipitor webpage contained a link that led to a webpage about Lipitor which contained a “...
Source: Pharmalot - September 2, 2011 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Caduet Chantix FDA Internet Search Engine Lipitor Misbranded drugs Norvasc Pfizer Web Page Web Site Webpage Website Source Type: blogs

Antibiotic Prescriptions for Kids Fall, But the News Isn’t All Goodemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
When kids get respiratory infections like bronchitis or the common cold, most times they don’t need antibiotics to get better. Many still receive the drugs, however, even after public-health campaigns warning against overuse. Unnecessarily administering the drugs does patients no good and can lead to antibiotic resistance — potentially rendering the drugs useless against serious infections. New stats out today from the CDC show that antibiotic prescribing rates for kids 14 and under have improved since the early 1990s. But the prescribing rate “remains inappropriately high,” the report says. Overall pre...
Source: WSJ.com: Health Blog - September 1, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: Antibiotics drugs Pediatrics Research Source Type: blogs

Safe Cosmetics Act Addresses Gaps in Safety Regulationsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Many U.S. users of cosmetics may not realize that they do not require FDA testing or approval and the federal agency is not authorized to require a manufacturer to recall unsafe products from the market. Because cosmetics are not regulated in the same way drugs are, it’s more difficult for consumers to make informed decisions, and the FDA has less power to regulate the cosmetics industry and respond to problems. The Safe Cosmetics Act of 2011, introduced by Janice Schakowsky (IL-D), is intended to help close some of these gaps in cosmetics regulation. The Act would give the government the power to recall unsafe cosme...
Source: Our Bodies Our Blog - September 1, 2011 Category: Health Medicine and Bioethics Commentators Authors: Rachel Tags: drugs & Pharmaceutical Companies Public Policy Source Type: blogs

Aging and Addictionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Addiction among older adults is a hidden and hushed problem. Signs and symptoms of alcohol or medication abuse can easily be mistaken for conditions related to aging. And even when friends or family members recognize signs of addiction, they often discount the need for intervention or treatment. With an estimated three million older Americans struggling with alcohol and drug misuse and abuse, Aging and Addiction is a much-needed resource. The authors, both experts in the field of addiction treatment and intervention, provide a respectful, definitive guide for recognizing and addressing substance abuse among older adults....
Source: Recovery Is Sexy.com - September 1, 2011 Category: Addiction Authors: Sparrow Tags: Addictions drugs Family Medications Recovery Books Treatment Aging and Addiction intervention medication abuse misuse and abuse Source Type: blogs

A.M. Vitals: Silicone Breast Implants Will Stay on Marketemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Tracking Implants: An FDA official said silicone breast implants made by Johnson & Johnson’s Mentor and Allergan will stay on the market, and that the agency will work with the companies to increase participation in post-approval studies, Dow Jones Newswires reports. Companies have struggled to maintain follow-up on the 80,000-plus women originally included in those studies, originally planned to last a decade, with Allergan tracking about 60.5% of them for two years and Mentor following 21% for three years. If more women aren’t tracked, the studies won’t be able to detect possible long-term health issues. E...
Source: WSJ.com: Health Blog - September 1, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs FDA Medical devices Nutrition Source Type: blogs

Looking At Risperdal For ADHD And Alternatives To Psychostimulant Drugs For ADHD Are You Up To Dateemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Being up to date in the ADHD drugs world requires a lot of study and dedication. Drugs come and go and there has been a lot of debate and controversy about the side effects of drugs such as Adderall, Concerta and Ritalin. Risperdal and ADHD is another popular choice. A recent survey by Consumer Reports asked over 900 parents of children with ADHD about which treatment options they had selected. They found that over 84% said that their kids had been treated with psychostimulants at some point in the treatment cycle. Are they really safe and are they effective in reducing some of the symptoms of restlessness, hyperactivity a...
Source: Life With ADHD - August 30, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD drugs Alternatives Looking Risperdal Source Type: blogs

JAMA Article Begs Key Questions About Case of Contaminated Heparinemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
There was a recent reminder of the case of the tainted heparin, which begged more questions than it answered.  (A case summary is appended to the end of this post, and nearly all our posts are here.)  The case is of fundamental importance because it involves the failure of pharmaceutical companies to fulfill their core mission, to supply pure, unadulterated drugs.   Three years later, how the heparin was adulterated, and who was responsible are still unknown. JAMA just published a major news article (Kuehn BM. As production goes global, drug supply faces greater risks to safety,...
Source: Health Care Renewal - August 30, 2011 Category: Health Medicine and Bioethics Commentators Tags: heparin Baxter JAMA adulterated drugs anechoic effect accountability Source Type: blogs

Nicotine as a Marker for Alcohol & Psychiatric Disordersemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CONCLUSIONS: Nicotine dependence represents a general marker of psychiatric comorbidity, particularly of addictive comorbidity. It may be used as a screening measure for psychiatric diagnoses in clinical practice as well as in future trials.Research report; Le Strat Y, Ramoz N, Gorwood P. In Alcohol-Dependent Drinkers, What Does the Presence of Nicotine Dependence Tell Us About Psychiatric and Addictive Disorders Comorbidity? Alcohol Alcohol. 2010 Jan 20. See also;Alcoholic, Addictive BehaviorsWernicke-Korsakoff SyndromeAre Families Affected by Alcoholism?What are the Styles of Enablers?Hazelden Books and ResourcesNEWYou Can Help an Alcoholic
Source: Twelve Step Facilitation.com - August 30, 2011 Category: Addiction Authors: Sparrow Tags: Addiction Alcohol Alcoholism Disease of addiction drugs Research Symptoms of addiction antisocial personality Anxiety depressive episode manic disorder Nicotine dependence panic disorder social phobia suicide attempt Source Type: blogs

The Multiple Sclerosis Spell-Checkeremail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The more I write about multiple sclerosis, the more I realize that I’m smarter than my computer about said topic. Sometimes I feel like my spell-checking software hasn’t caught up with the vernacular of our disease. Other times, I feel like we’re just making up words for stuff — oft, we are! Myelin, Cog-Fog, Assistive, PML, CCSVI… not something your everyday word processing program recognizes; and I need it too! In my current state, I find myself relying more and more on the brain under my fingertips more than I trust my own T-Cell infested gob but squiggly red, blue or green highlights (GREAT! Now I’m to u...
Source: Life with MS - August 30, 2011 Category: Other Conditions Authors: admin Tags: Diagnosis MS MS and fatigue MS blog MS diagnosis Multiple Sclerosis health brain cognitive ability with ms living with multiple sclerosis MS progression multiple scelrosis multiple sclerosis drugs Source Type: blogs

A.M. Vitals: Pfizer Takes New Tack With More Targeted Drugsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
“Niche Blockbusters”: Pfizer’s newly approved lung-cancer therapy crizotinib, to be sold under the brand name Xalkori, represents a relatively new tack for the pharma giant: a drug aimed at a small group of patients with a serious disease whom tests show will likely benefit from the treatment, the WSJ reports. Drug makers can bring these potential “niche blockbusters” to market quickly and more cheaply than drugs aimed at a mass audience, and because the medical need is dire, insurers will pay up for them. Xalkori will sell for $115,200 per year. Asking the Uninsured: The Kaiser Family Foundationâ...
Source: WSJ.com: Health Blog - August 30, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs Insurance Obama Administration Pregnancy Health-Care Overhaul Source Type: blogs

FDA Approves A New, Monoclonal Antibody For Lymphomaemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Recently, the FDA announced its approval, upon accelerated review, of a new drug, Adcetris (brentuximab) for patients with Hodgkin’s lymphoma that has relapsed after bone marrow transplant and for some patients with T-cell anaplastic large cell lymphoma (ALCL). This interests me for a lot of reasons, among them that I used to work in the field of lymphoma immunology and spent some time in my life studying molecules like CD30, the protein to which the new antibody binds. First, a mini-primer on the disease and numbers of patients involved: (more…) *This blog post was originally published at Medical Lessons*
Source: Better Health - August 29, 2011 Category: Health Medicine and Bioethics Commentators Authors: Elaine Schattner, M.D. Tags: News Adcetris ALCL Cancer drugs Cancer Treatment Communication FDA FDA Approval Hodgkin's Lymphoma Medical News Office of Oncology Drug Products Pathology Pharmalot Seattle Genetics Source Type: blogs

Don’t use medicines affected by Hurricane Ireneemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
If Hurricane Irene left you with flooding and water damage, chances are food, drinking water, and even medicines in your home were affected, exposing you and your family to potential illness and other serious health risks. To lessen these risks, the Food and Drug Administration is recommending that you discard any drug products—even those in their original containers—that have come into contact with flood or contaminated water. That includes capsules, tablets, and liquids in drug containers with screw-top caps, snap lids, or droppers and injections, inhalers, and skin medications. If needed, contact your doctor...
Source: Consumer Reports Health Blog - August 29, 2011 Category: Health Medicine and Bioethics Commentators Authors: Consumer Reports News Tags: Drug safety Health News Over-the-counter drugs Prescription drugs Source Type: blogs

A.M. Vitals: Blood-Thinner From Bristol-Myers, Pfizer Beats Warfarinemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Superior to the Standard: Data from an 18,201-person study show that apixaban, a blood thinner being developed by Bristol-Myers Squibb and Pfizer, reduced the risk of stroke in atrial fibrillation patients by 21% and the risk of death by 11% compared to the standard treatment, warfarin, the WSJ reports. Apixaban also cut the risk of bleeding by 31% compared to warfarin. The drug will be submitted to the FDA for approval this year, the paper says. Bird Flu, Again: The United Nations is warning that a strain of avian flu against which current vaccines may not protect is spreading among birds in China and Vietnam, the Associa...
Source: WSJ.com: Health Blog - August 29, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs FDA Heart Disease Pediatrics Source Type: blogs

The Dangers of Overprescribed Adhd Medicationsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Attention deficit hyperactivity disorder (ADHD) has become the fastest growing diagnosed disorder among children under the age of 18. Many children in countries such as the US, New Zealand and Australia are being prescribed medications at an alarming rate. As the FDA requires ADHD drugs to carry warning labels, the overmedication of children with ADHD is becoming a real concern. Most ADHD drugs are stimulant that contain amphetamine. Various side effects have been reported from taking these drugs. Some of them tend to suppress feelings of any kind, making children unhappy. Some are addictive and prone to substance abuse. I...
Source: Life With ADHD - August 28, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD drugs Dangers Medications OverPrescribed Source Type: blogs

ADHD News About Substance Abuse Smoking And Drugsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
This study confirms that children and teens with ADHD are more likely to have problems with drug abuse, smoking and bad behavior. The children studied were ten years old and they were actually followed for a full ten more years until they reached the age of twenty. The teens with ADHD were one and a half times more likely to be involved in substance abuse and alcohol.  The interesting fact from this study shows that those teenagers who had come to terms with the Read More
Source: Life With ADHD - August 27, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD Research About abuse drugs News Smoking Substance Source Type: blogs

A.M. Vitals: PharMerica Adopts Poison-Pill Provisionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Poison Protection?: Pharmacy-services provider PharMerica said it adopted a poison-pill provision to prevent unwanted takeover bids, Dow Jones Newswires reports. Earlier this week the company rejected a $15-per-share bid from Omnicare, saying it undervalued PharMerica and that regulatory risk was too high. Omnicare said it was still willing to talk with PharMerica about how to “allocate” risk that a deal would run into antitrust hurdles. Cracking Down on Papayas: The FDA has restricted papaya imports from Mexico after inspections showed more than 15%, from a host of different producers, were tainted, Reuters repo...
Source: WSJ.com: Health Blog - August 26, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: CDC drugs FDA Food Safety M&A Vaccines Source Type: blogs

Brief Interventionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Is Insufficient for Medical Inpatients With Unhealthy DrinkingData show that brief intervention reduces consumption and consequences among outpatients with unhealthy, but not dependent, alcohol use. To assess whether brief interventions work among medical inpatients with unhealthy drinking,* researchers randomized 341 of such patients to a 30-minute session of motivational counseling in the hospital or to usual care.Most subjects had alcohol dependence, were unemployed during the previous 3 months, used other drugs, and had substantial psychiatric symptoms. Almost half were hospitalized for an alcohol-related medical diag...
Source: Twelve Step Facilitation.com - August 25, 2011 Category: Addiction Authors: Sparrow Tags: 12-Step Groups Adjunctive therapy Alcohol Alcoholics Anon Alcoholism Brief Intervention Brief-TSF Contrast to other models Relapse prevention Research comorbidity dependence drugs outpatients Source Type: blogs

Drug Shown To Protect Obese Mice From The Diseases Of Obesityemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
I usually choose not to write about the “new new scientific thing” that gets picked up by the press,  because early research is usually not reproducible and good science takes a long time to validate as true.  But since we know that mice and rats that are kept on low-calorie diets live 30% longer (and healthier) than their fat cohorts, I was interested in a new research compound, SRT-1720,  that was shown to protect obese mice from diseases of obesity.  Fat mice lived 44% longer if they were given this drug. The “designer” drug works by (more…) *This blog post was originally publ...
Source: Better Health - August 25, 2011 Category: Health Medicine and Bioethics Commentators Authors: Toni Brayer, M.D. Tags: News Research Anti-Aging drugs Designer Drug Diet Diet drugs Eating Habits Fat Healthy Insulin Sensitivity Liver Longevity Low-calorie diets Metabolism Mice Obese Obesity Epidemic Resveratrol sirtuins SRT-1720 Source Type: blogs

A.M. Vitals: Steve Jobs’ Health Strugglesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Stepping Aside: Steve Jobs, who ended his tenure as Apple’s CEO yesterday, has faced health problems over the years including a rare form of pancreatic cancer and a liver transplant, the WSJ reports. A physician not involved with Jobs’ care tells the paper a recurrence of the cancer is more likely than complications from the transplant. Jobs, who becomes chairman of Apple, has been on medical leave since January. An Apple spokesman didn’t respond to a WSJ request for comment. Tit for Tat: Scientists have infected mosquitoes with Wolbachia bacteria in an attempt to curb the insects’ ability to spread the...
Source: WSJ.com: Health Blog - August 25, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs Source Type: blogs

Best Medicine for Adhd it May Come With a Suicide Warningemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Is there a ADHD NEW medication which has no side effects? Many parents are asking this question as they look around desperately for some wonder drug which will be the best medication for ADHD! As the numbers of children with mental disorders seems to spike every year (latest figures show that 10% of American children suffer from a mental or emotional disorder), attention deficit hyperactivity disorder and other behavioural disorders are still at the top of the list. If ADHD continues into adulthood untreated, then these adults have a much higher likelihood of becoming smokers (60%) and drug abuse (about 50%). Some estimate...
Source: Life With ADHD - August 24, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD drugs Best Come medicine With Source Type: blogs

FDA warns high doses of Celexa linked to heart problemsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
People should not take more than 40 milligrams a day of the antidepressant citalopram (Celexa and generic) because higher doses appear to trigger potentially fatal heart rhythm problems, the Food and Drug Administration said Wednesday. People at greatest risk include those with heart conditions or low potassium or magnesium levels. The FDA's warning is based on reports it received of people taking the drug who developed abnormal changes in the electrical activity of the heart that could lead to deadly heart rhythm conditions. In addition, a study involving 119 adults found that higher doses of citalopram (up to 60 mg per ...
Source: Consumer Reports Health Blog - August 24, 2011 Category: Health Medicine and Bioethics Commentators Authors: Consumer Reports News Tags: Drug safety Health News Heart Prescription drugs Source Type: blogs

Google to Pay $500 Million Over Online Pharmacy Adsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
It’s official: Google is paying $500 million to settle a Justice Department investigation into the company’s acceptance of ads from online Canadian pharmacies targeting U.S. consumers. Here’s the WSJ story and here’s the WSJ Law Blog’s post. Here’s the Justice Department’s statement. The DOJ says Google should have known as early as 2003 that the pharmacies were using the company’s AdWords program to market to U.S. residents. Importing drugs to U.S. consumers is “almost always unlawful because the FDA cannot ensure the safety and effectiveness of foreign prescription drugs that ...
Source: WSJ.com: Health Blog - August 24, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: Advertising drugs Source Type: blogs

A.M. Vitals: Plant-Based Diet Lowered Cholesterol More than Cutting Fatemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Food as Medicine: People who ate a diet rich in plant-based foods such as nuts, soy, plant-based margarine spreads, barley and oats saw levels of their “bad” cholesterol drop 13% more than people who simply cut back on saturated fats, the WSJ reports. Results from the randomized trial, published in the Journal of the American Medical Association, add to the evidence suggesting it’s better to replace dietary saturated fats with healthy fats rather than with simple carbohydrates, an expert tells the paper. Interpreting Results: Another study appearing in JAMA, this one a review of previously published research...
Source: WSJ.com: Health Blog - August 24, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs Heart Disease M&A Nutrition Research Source Type: blogs

Is it Really Mind Over Matter? The Mind and Body Are Oneemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
You have probably heard the phrase mind over matter, which implies the mind and matter are separable.  Or maybe you have heard it’s all in your head, or it’s mental.  Both of these phrases imply the separation of mind and brain (or body). So to explore this issue, I’d like to share some videos that discuss the unity of mind-body.  They can help us better understand how inseparable the mind and brain (body) really are. Mind vs. Brain: In the above video, Yale psychologist Paul Bloom says, “The mind is a product of the brain.  The mind is what the brain does.” Can we overload our brains? Steven...
Source: World of Psychology - August 24, 2011 Category: Psychiatrists and Psychologists Authors: Jamie Hale Tags: Brain and Behavior General Psychology Random Brain Bits Abortion Debate Bad Behavior Brain Chemistry Brain Damage Brains Dichotomy Fatal Flaws Incapacity Mental Disabilities Mind Altering drugs Mind And Body Mind And Matter Source Type: blogs

A.M. Vitals: How Men and Women Sleep Differentlyemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Men and Women, Sleeping: Men and women sleep differently, with women experiencing deeper sleep, waking up fewer times during the night, and tolerating a lack of shut-eye better than men — even as men report greater overall satisfaction with their sleeping patterns, the WSJ reports. Research into gender and sleep differences may help explain the generally better health status of women compared to men, the paper says. Hip Problems: Complaints about metal-on-metal hip implants have risen by more than 5,000 since January as some patients have experienced problems with the devices and had them removed, the New York Times r...
Source: WSJ.com: Health Blog - August 23, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: Cancer drugs Medical devices Research Sleep Source Type: blogs

PARP Inhibitor Olaparib Has Activity in High-Grade Serous Ovarian Cancer Without Inherited BRCA1 or BRCA2 Gene Mutationsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Researchers affiliated with the British Columbia Cancer Agency reported Phase 2 clinical study results indicating that advanced ovarian cancer, with and without germline (inherited) BRCA 1 or BRCA 2 gene mutations, responded to treatment with the PARP inhibitor olaparib. The Phase 2 study results were published online in the August 21 edition of The Lancet [...]
Source: Libby's H*O*P*E* - August 22, 2011 Category: Cancer Authors: Paul Cacciatore Tags: Clinical Trial Results Novel Therapies Pipeline drugs AZD2281 BRCA gene mutations British Columbia Cancer Agency DNA repair pathway germline mutations homologous recombination Karen A. Gelmon M.D. Melinda L. Telli M.D. NYU School of Source Type: blogs

Alternative Treatment for Adhd is Your Medicine Chest Lockedemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Parents were shocked by a recent report which stated that a majority of teenagers engaged in dealing in ADHD drugs (such as Ritalin and Strattera and Vyvense) had gotten their supplies from the family medicine chests ! Parents are now becoming much more aware of alternative medicines for ADHD and know that there are alternatives out there which will not turn their children into drug users and ruin their childhood and adolescence. Teacher Knows Best? Many thousands of ADHD children are treated with powerful psychostimulant drugs. I read a recent blog post about a thirteen year old boy whose teacher insisted that he shou...
Source: Life With ADHD - August 21, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD drugs alternative Chest medicine treatment Your Source Type: blogs

New Cancer Treatment Gains Momentumemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
You heard about it first on Patient Power when, a couple of years ago, we interviewed Dr. Andrew Lowy, oncology surgeon at UC San Diego Medical Center. He explained how some patients with advanced cancer spread in their abdomen could benefit from an open surgery – perhaps as much as nine hours long – where, after snipping out visible cancer – the organs are bathed in heated chemotherapy for 90 minutes. You may recall the story of Jennifer Ambrose, a young mom from suburban Chicago, who developed cancer of the appendix. She tracked down Dr. Lowy after spotting him on the Internet. She traveled to San Diego, had the ...
Source: Better Health - August 18, 2011 Category: Health Medicine and Bioethics Commentators Authors: AndrewSchorr Tags: Opinion Research Cancer Cancer drugs Chemotherapy Dr. Lowy Hot Chemotherapy Immunotherapy Jennifer Ambrose New York Times Oncology Powerful Patient Powerful Patients Web-Savvy Patient Source Type: blogs

A.M. Vitals: FDA Approves Targeted Melanoma Treatment From Roche, Daiichiemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Melanoma Treatment Option: The FDA approved vemurafenib, a treatment from Roche Holding and Daiichi Sankyo aimed at the half of metastatic melanoma patients whose cancer is driven by a specific genetic mutation, the WSJ reports. The treatment, to be sold under the brand name Zelboraf, will be taken for about six months and will cost about $56,400, according to Roche. Back Too Soon: Research published in the American Journal of Obstetrics & Gynecology suggests most physicians are screening women for cervical cancer too frequently, Reuters reports. CDC researchers found that physicians are bringing back women with negati...
Source: WSJ.com: Health Blog - August 18, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: Cancer drugs FDA Research Screening Surgery Source Type: blogs

The safer management of controlled drugs: Annual report 2010email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Scan or click 'The safer management of controlled drugs annual report 2010' Title: The safer management of controlled drugs annual report 2010 The Skinny: Recommends that: Chief executives and accountable officers should continue to keep the safe management of controlled drugs a high priority on their organisation’s agenda during the reorganisation of the NHS to ensure that the gains in safety made over the past four years are not lost. Chief executives and accountable officers should ensure that CD LINS have robust working arrangements and are fit for purpose and adequately prepared for the transition. ...
Source: Fade Library - August 17, 2011 Category: Medical Librarians Authors: western4uk Tags: Ooops Missed Category! Annual Reports Drug information Grey Literature Patient Safety Prescription drugs Source Type: blogs

Making best use of medicines: Report of a Department of Health roundtable event hosted by The King’s Fundemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: Making best use of medicines: Report of a Department of Health roundtable event hosted by The King’s Fund Scan or click to download ‘Making best use of medicines: Report of a Department of Health roundtable event hosted by The King’s Fund’ The Skinny: Considers the implications of the research findings of the scale, causes and cost of medicines wasted, published by university of London and York Health Economics Consortium, to develop a practical plan for collaborative action to minimise wastage of medicines and improve health outcomes. Publisher: DH Published: 09/08/11 Size: 16p Filed under: Ooops...
Source: Fade Library - August 17, 2011 Category: Medical Librarians Authors: western4uk Tags: Ooops Missed Category! Cost control drugs Financial Management Grey Literature Medicinal products Source Type: blogs

Women Still Using Pai You Guo Supplement Despite Banemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
In 2009 the FDA recalled an over-the-counter weight-loss supplement called Pai You Guo because it contained two drugs — sibutramine, the active ingredient in the now-defunct Abbott drug Meridia, and phenolphthalein, an ingredient removed from over-the-counter laxatives after it was pegged as a potential carcinogen. Sibutramine can significantly raise blood pressure and pulse rate and might harm patients with a history of heart problems, the FDA said. Well, the banned supplement never went away, at least in one area of the country, according to a new study. The study, published online in the Journal of General Interna...
Source: WSJ.com: Health Blog - August 16, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs FDA Research Supplements Source Type: blogs

Is Addiction Simply a Brain Disease? It Is Nowemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Among addiction experts and researchers, there’s been a long-running debate as to whether drug or alcohol addiction, and even “behavioral addictions” such as compulsive gambling, are actual diseases or not. It’s not just a matter of semantics — if researchers can trace addiction’s root causes to an actual medical malfunction in the brain, perhaps that disease could be directly treated. Who am I to disagree with a “four-year process with more than 80 experts actively working on it?” Their result? Addiction is a “chronic brain disorder and not simply a behavioral problem....
Source: World of Psychology - August 16, 2011 Category: Psychiatrists and Psychologists Authors: John M. Grohol, PsyD Tags: Addiction Brain and Behavior General Mental Health and Wellness Policy and Advocacy Addiction Experts Addiction Medicine Addictive Behaviors Alcohol Addiction Alcohol And Other drugs Anterior Cingulate Cortex Behavioral Response Br Source Type: blogs

A.M. Vitals: Judge Rules Pfizer’s 2019 Viagra Patent is Validemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Viagra Protection: A federal judge ruled yesterday that a Pfizer patent on the erectile-dysfunction treatment Viagra is valid and enforceable, protecting the blockbuster drug against generic competition until 2019, the WSJ reports. Teva Pharmaceutical had proposed a generic version of the drug, arguing that certain claims of that 2019 Pfizer patent were invalid, the paper says. Cheap Screening: Hospitals are advertising inexpensive low-dose CT scans for current and former smokers on the heels of a government study that found such lung-cancer screening can save lives in a certain group of people, Kaiser Health News reports....
Source: WSJ.com: Health Blog - August 16, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: AIDS drugs Health costs Hospitals Legal Medicaid Medicare Source Type: blogs

5 Facts About Adhd And Homeopathyemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
It is alarming to learn that ADHD drugs like Ritalin (methylphenidate) are not fully understood as regards how they actually work on the brain and neither are their side effects fully documented. Any drug will have side effects and very often the full extent of these are not known when clinical trials are done. They are only discovered after masses of patients take them. That is the case with the ADHD drugs because now there are serious doubts about their actual effectiveness and their risks. This is why ADHD and homeopathy are deservedly becoming more popular. ADHD and homeopathy are a safer option The first fact is th...
Source: Life With ADHD - August 15, 2011 Category: Other Conditions Authors: ADHD Dad Tags: ADHD drugs About Facts homeopathy Source Type: blogs

J&J Recall Watch: Tylenol Cold Gelcaps Pulledemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Johnson & Johnson is recalling from wholesalers and stores almost 2.5 million packages of Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps. The company says the recall — which doesn’t apply to consumers who already have the drug at home –  stems from the discovery of higher-than-expected levels of chlorpheniramine ammonio acetate (CPAA) in certain capsules. Dow Jones Newswires reports the compound is formed by the combination of two product ingredients and hasn’t been associated with any health problems. We’ve been keeping tabs on J&J’s string of recalls, which cost it...
Source: WSJ.com: Health Blog - August 15, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs J&J CPAA Source Type: blogs

Pharma-Page Facebook Commenters, Start Your Enginesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Social media can be a minefield for pharma companies given the FDA’s requirements to keep product information fairly balanced and promote only approved uses of drugs. Until now, Facebook has helped drug companies control the information on their sponsored pages by disabling the comment  function. That’s supposed to end today. As the Washington Post reports, most pharma pages — except those for specific prescription products — will now allow reader input. (The change doesn’t seem to completely be in effect yet.) “What [Facebook says] is that their philosophy is about promoting dialogue, ...
Source: WSJ.com: Health Blog - August 15, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: drugs FDA Social media Source Type: blogs

Piloting Payment by Results for Drugs Recovery – draft outcome definitionsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Title: Piloting Payment by Results for Drugs Recovery – draft outcome definitions Scan or click to download 'Piloting Payment by Results for Drugs Recovery – draft outcome definitions' The Skinny: The Government has set the following high-level outcomes: Free from drug(s) of dependence Offending Employment Health and well-being A Co-design Group has developed proposals to measure these outcomes and set eligibility criteria and now invites comments from the sector on draft proposals. Publisher: DH Published: 13/07/11 Size: 13p. Filed under: Ooops Missed Category! Tagged: Addiction, Addiction units, Alcohol A...
Source: Fade Library - August 15, 2011 Category: Medical Librarians Authors: western4uk Tags: Ooops Missed Category! Addiction Addiction units Alcohol Abuse Alcohol abuse services Alcohol and drug consumption Clinical Governance Drug Abuse drugs of Abuse Grey Literature Health Outcomes Health Services Quality Assurance Qu Source Type: blogs

A.M. Vitals: Ground-Turkey Salmonella Outbreak Raises Antibiotics Questionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Raising Questions: The debate over whether antibiotics should be used less frequently in livestock has been revived by the recent recall of ground turkey tainted by salmonella bacteria that is resistant to many of the drugs, the WSJ reports. Food-safety experts say that routine use of antibiotics in feed as a preventive can promote antibiotic-resistant bacteria and threaten human health, while industry groups counter that the practice reduces animal diseases, promotes growth and keeps meat prices low, the paper says. Crop Inspections: Mushrooms grown about 25 miles away from the Japanese nuclear plant damaged in the March ...
Source: WSJ.com: Health Blog - August 15, 2011 Category: Health Medicine and Bioethics Commentators Authors: Katherine Hobson Tags: Autism drugs FDA Food Safety Generics Source Type: blogs